NCT Number: NCT00145067
Osteoporosis Disease Management Demonstration Project (0000-040)
The purpose of the study is to evaluate the impact disease management interventions in treatment compliance among post-fracture and osteoporosis patients.
Looking for future studies?
Notify MeKey information
Conditions
Age range
60 year and older
Sex eligibility
Female
Study type
Interventional
Phase
Not applicable
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Members of of the Kaiser Permanente Health Plan who have fractured a bone.
Exclusion criteria
- Individuals who are not members of the Kaiser Permanente Health Plan.
Treatment and study plan
Primary outcomes
-
Treatment persistence
Secondary outcomes
-
Patient satisfaction and knowledge
Sponsors and collaborators
Lead sponsor
Merck Sharp & Dohme LLC
Industry
Registry information
Official study title
Three Methods of Delivering Health Care for Secondary Prevention of Osteoporosis
Important dates
- Study start
- 2003
- Primary completion
- 2006
- Study completion
- 2006
- First posted
- Sep 5, 2005
- Registry last updated
- Nov 3, 2015
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Osteoporosis Awareness in Chronic Spinal Cord Injury
NCT07725081
Attitudes, Behavior
Afyonkarahisar, Turkey (Türkiye)
View Trial DetailsFinding the Optimal Resistance Training Intensity For Your Bones
NCT05541432
Behavior, Bone Diseases
Waterloo, Ontario, Canada
View Trial DetailsTrial of Parkinson's And Zoledronic Acid
NCT03924414
Atypical Parkinsonism, Autonomic Nervous System Diseases
Scottsdale, Arizona, United States
View Trial DetailsEvaluation of Osteoporosis Support After a Severe Osteoporotic Fracture in Women Over 50 Years in University Hospital
NCT02924545
Bone Diseases, Bone Diseases, Metabolic
Nîmes, France
View Trial Details